Intermittent Oro-Esophageal Tube Feeding vs. Nasogastric Tube Feeding in Infants With Pierre Robin Syndrome
NCT06178562 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2024-03-05
Summary
This was a randomized controlled study. The infants enrolled were randomly divided into the IOE group (with Intermittent Oro-Esophageal Tube Feeding, n=25) and the PNG group (with Nasogastric Tube Feeding, n=23), all receiving systemic therapy. Before and after 4-week treatment, pulmonary infection, swallowing function, nutritional status and body weight between the two group were compared.
Conditions
- Pierre-Robin Syndrome
- Dysphagia
Interventions
- BEHAVIORAL
-
systematic therapy
Both groups were given systematic therapy according to the routine treatment plan for PRS for 4 weeks. The main intervention measures included: 1) non-invasive ventilator treatment, generally at least once every night and typically not exceeding continuous daily usage.; 2) attention to feeding and sleeping positions, with a recommended sleeping position of lateral recumbent and the head of the bed raised by 20-30°; 3) swallowing function training, such as tongue muscle stretching training, assisted anterior jaw protrusion training, lemon ice stimulation to the soft palate, pharyngeal wall, etc., generally 5 days per week, twice per day, 5-20 minutes each time; 4) pulmonary ultrashort wave therapy, generally at least 2-3 times a week, and not more than once a day; 5) physical therapy, such as intensive training for gross motor functions including lifting the head, turning over, sitting, crawling, standing, etc., generally 3-5 days per week, 1-2 times per day, 5-20 min each time.
- DEVICE
-
PNG
In PNG group, disposable gastric tubes were used for feeding to provide nutritional support. Each feeding was administered by a nurse using the infant's mother's breast milk through the tube. The amount of each feeding varied from 20 to 100 ml depending on the age of the infant, with feedings given every 2 to 3 hours, approximately 10 times per day. The duration of each feeding procedure ranged from 10 to 20 minutes. The total daily intake ranged from 200 to 1000 ml. Each tube was kept indwelling for 5 to 7 days. When the tube needed to be replaced, it was removed after the last feeding of a day and a new tube was to be inserted through the other nostril on the following morning to continue the nutritional support.
- DEVICE
-
IOE
The specific procedure was as follows: the infant was placed in a semi-recumbent or sitting position with the head fixed. Before each feeding, the infant's oral and nasal secretions were to be cleared. An intermittent oro-esophageal tube (Appendix) was appropriately lubricated with water on the head part. The professional medical staff held the tube and slowly inserted it through one side of the mouth into the upper part of the esophagus. The depth of insertion depended on the patient's age and height. After each feeding, the tube was immediately removed, and the patient was held upright for at least 30 minutes in case of reflux.
Sponsors & Collaborators
-
Zeng Changhao
lead OTHER
Principal Investigators
-
Nieto Luis, Doctor · Site Coordinator of United Medical Group located in Miami
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Month
- Max Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-15
- Primary Completion
- 2023-06-01
- Completion
- 2023-06-30
Countries
- China
Study Locations
More Related Trials
-
Feasibility of Aerodigestive Stimulation Therapy Trial
NCT06118697 ·Status: RECRUITING ·Phase: NA
-
Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome
NCT05298085 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Tolerance and Safety of Early Enteral Nutrition in Children After Percutaneous Endoscopic Gastrostomy Placement
NCT02777541 ·Status: UNKNOWN ·Phase: NA
-
Quality of Life in Patients With Short Bowel Syndrome Treated Without and With Teduglutide - a Prospective Nested Matched Pair Analysis
NCT04733066 ·Status: UNKNOWN
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
NCT00172185 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older
NCT05027308 ·Status: COMPLETED ·Phase: PHASE3
-
Short Bowel Syndrome and Teduglutide Versus Placebo
NCT02099084 ·Status: COMPLETED ·Phase: PHASE4
-
Saline Enema Administration in Meconium Obstruction of Prematurity and Impact on the Resolution, Feeds, Microbiome, and Gut-brain Axis.
NCT06048614 ·Status: RECRUITING ·Phase: NA
-
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
NCT02682381 ·Status: COMPLETED ·Phase: PHASE3
-
TubeClear® Evaluation in Pediatric Patients (Phase I)
NCT02724631 ·Status: TERMINATED ·Phase: NA
-
Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome
NCT03571516 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study in Infant With SBS
NCT02865122 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
NCT03197662 ·Status: COMPLETED ·Phase: PHASE2
-
Amoxicillin for Enteral Nutrition Intolerance in Pediatric Intensive Care Unit
NCT05828758 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation
NCT02290626 ·Status: WITHDRAWN ·Phase: NA
-
Thoracic Neuromodulation for Diabetic Gastroparesis
NCT05273788 ·Status: RECRUITING ·Phase: PHASE1
-
Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support
NCT02980666 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)
NCT02340819 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
NCT00081458 ·Status: COMPLETED ·Phase: PHASE3
-
Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children
NCT01075789 ·Status: TERMINATED ·Phase: NA
-
Comparison of Two Endoscopically Placed Nasojejunal Probes
NCT02705027 ·Status: UNKNOWN ·Phase: NA
-
Effects and Safety of Infusion of Low-Doses of Methylprednisolone in Early ALI and ARDS in Children
NCT01757899 ·Status: WITHDRAWN ·Phase: PHASE2
-
Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children
NCT05724550 ·Status: COMPLETED ·Phase: NA
-
Neuromuscular Electrical Stimulation for Children With Dysphagia
NCT06309056 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Diabetic Gastroparesis Efficacy/Safety Study of TZP-102
NCT01664637 ·Status: TERMINATED ·Phase: PHASE2